To access the full blog via Microsoft Sway, click here
MHRA Drug Safety Update September 2024 (issued in advance of monthly newsletter)
Posted: Wednesday, September 11, 2024
Category - Medicines Update
Posted: Wednesday, September 11, 2024
Category - Medicines Update
To access the full blog via Microsoft Sway, click here
Posted: Tuesday, September 10, 2024
Category - Medicines Update
This is the first in a series of blogs on overprescribing with future focuses on inappropriate polypharmacy, transitions of care, data and digital, and non-pharmacological choices.
It is part of a wider public campaign launched by NHSGGC, aiming to reduce medicines waste by sharing information and advice with staff, patients and members of the public.
Posted: Monday, September 9, 2024
Category - Medicines Update
Key messages:
Posted: Friday, September 6, 2024
Category - Medicines Update
To access the full blog via Microsoft Sway, click here
Posted: Wednesday, August 28, 2024
Category - Medicines Update
Key Messages
Posted: Wednesday, August 28, 2024
Category - Medicines Update
Prescribers should ensure that the Patient Information Leaflet (PIL) (attached to the PAM chart) is issued to the patient/carer as soon as possible. The gentamicin PIL now asks patients to report any pre-existing issues with hearing or balance as well as personal or familial history of mitochondrial disease and any previous hearing or balance issues relating to antibiotics.
Posted: Wednesday, August 28, 2024
Category - Medicines Update
Key messages:
The GGC Creatinine Clearance (CrCl) calculator will now use Adjusted Body Weight (AdjBW) rather than Maximum Body Weight (MBW) to estimate renal function for patients who weigh more than their Ideal Body Weight (IBW).
AdjBW provides a better estimate of renal function for patients who are overweight or obese.
AdjBW is IBW plus 40% of the difference between ideal and actual body weight.
Posted: Monday, August 26, 2024
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary
Posted: Friday, August 23, 2024
Category - Medicines Update
To access the full blog via Microsoft Sway, click here
Posted: Friday, August 9, 2024
Category - Medicines Update
The Emergency Care Summary (ECS) for patients with a diagnosis of schizophrenia may show no record of any antipsychotic prescription; this may indicate they are prescribed a specialist medicine such as clozapine or an antipsychotic depot.